| Literature DB >> 35372271 |
Priya Verma1, Anubha Srivastava1, Poonam Tandon1, Manishkumar R Shimpi2,3.
Abstract
The computational modeling supported with experimental results can explain the overall structural packing by predicting the hydrogen bond interactions present in any cocrystals (active pharmaceutical ingredients + coformer) as well as salts. In this context, the hydrogen bonding synthons, physiochemical properties (chemical reactivity and stability), and drug-likeliness behavior of proposed nicotinamide-oxalic acid (NIC-OXA) salt have been reported by using vibrational spectroscopic signatures (IR and Raman spectra) and quantum chemical calculations. The NIC-OXA salt was prepared by reactive crystallization method. X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) techniques were used for the characterization and validation of NIC-OXA salt. The spectroscopic signatures revealed that (N7-H8)/(N23-H24) of the pyridine ring of NIC, (C═O), and (C-O) groups of OXA were forming the intermolecular hydrogen bonding (N-H⋯O-C), (C-H⋯O═C), and (N-H⋯O═C), respectively, in NIC-OXA salt. Additionally, the quantum theory of atoms in molecules (QTAIM) showed that (C10-H22⋯O1) and (C26-H38⋯O4) are two unconventional hydrogen bonds present in NIC-OXA salt. Also, the natural bond orbital analysis was performed to find the charge transfer interactions and revealed the strongest hydrogen bonds (N7-H8⋯O5)/(N23-H24⋯O2) in NIC-OXA salt. The frontier molecular orbital (FMO) analysis suggested more reactivity and less stability of NIC-OXA salt in comparison to NIC-CA cocrystal and NIC. The global and local reactivity descriptors calculated and predicted that NIC-OXA salt is softer than NIC-CA cocrystal and NIC. From MESP of NIC-OXA salt, it is clear that electrophilic (N7-H8)/(N23-H24), (C6═O4)/(C3═O1) and nucleophilic (C10-H22)/(C26-H38), (C6-O5)/(C3-O2) reactive groups in NIC and OXA, respectively, neutralize after the formation of NIC-OXA salt, confirming the presence of hydrogen bonding interactions (N7-H8⋯O5-C6) and (N23-H24⋯O2-C3). Lipinski's rule was applied to check the activeness of salt as an orally active form. The results shed light on several features of NIC-OXA salt that can further lead to the improvement in the physicochemical properties of NIC.Entities:
Keywords: atoms in molecules; hydrogen bonds; natural bond orbital; nicotinamide–oxalic acid salt; reactivity–property study; spectroscopic signatures
Year: 2022 PMID: 35372271 PMCID: PMC8965448 DOI: 10.3389/fchem.2022.855132
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1Optimized structure of NIC–OXA salt with atom numbering adopted in this study. NIC–OXA, nicotinamide–oxalic acid.
Observed and calculated bond length and stretching frequency of modes involved in hydrogen bonding.
| Molecule | C–N of pyridine ring of NIC | C═O group of OXA | C–H of pyridine ring of NIC | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Bond length (Å) | Stretching frequency | Bond length (Å) | Stretching frequency | Bond length (Å) | Stretching frequency | ||||
| — | IR | Raman | — | IR | Raman | — | IR | Raman | |
| Experimental | |||||||||
| NIC | 1.3408 | 1,264 | 1,276 | — | — | — | 1.0830 | 3,013 (C6–H12) | 3,009 (C6–H12) |
| OXA | — | — | — | 1.2100 | 1,689 (C2═O3) | 1,691 (C2═O3) | — | — | — |
| — | — | — | 1.2100 | 1,689 (C6═O7) | 1,691 (C6═O7) | — | — | — | |
| NIC–OXA salt | 1.3446 | 1,267 | 1,260 | 1.2150 | 1,695 (C3═O1) | 1,689 (C3═O1) | 1.0190 | 3,095 (C10–H22) | 3,102 (C10–H22) |
| 1.3446 | 1,267 | 1,260 | 1.2150 | 1,695 (C6═O4) | 1,689 (C6═O4) | 1.0190 | 3,095 (C26–H38) | 3,102 (C26–H38) | |
| Theoretical | |||||||||
| NIC | 1.3350 (C6–N3) | 1,272 | 1,272 | — | — | — | 1.0868 | 3,010 (C6–H12) | 3,010 (C6–H12) |
| OXA | — | — | — | 1.1988 | 1788 (C2═O3) | 1788 (C2═O3) | — | — | — |
| — | — | — | 1.1988 | 1788 (C6═O7) | 1788 (C6═O7) | — | — | — | |
| NIC–OXA salt | 1.3397 (C18–N7) | 1,268 | 1,268 | 1.2082 | 1759 (C3═O1) | 1759 (C3═O1) | 1.0832 | 3,071 (C10–H22) | 3,071 (C10–H22) |
| 1.3397 (C34–N23) | 1,268 | 1,268 | 1.2082 | 1759 (C6═O4) | 1759 (C6═O4) | 1.0832 | 3,071 (C26–H38) | 3,071 (C26–H38) | |
Note. NIC, nicotinamide; OXA, oxalic acid.
FIGURE 2Experimental and calculated FT-IR absorbance spectra of NIC–OXA salt in the region of 400–4,000 cm−1. FT-IR, Fourier transform IR; NIC–OXA, nicotinamide–oxalic acid.
FIGURE 3Experimental and calculated FT–Raman spectra of NIC–OXA salt in the region of 400–3,620 cm−1. FT, Fourier transform; NIC–OXA, nicotinamide–oxalic acid.
FIGURE 4AIM molecular graph showing ring critical points (RCPs; yellow small balls), bond critical points (BCPs; red small balls), and bond paths (pink lines) of NIC–OXA salt calculated with B3LYP/6-311++G(d, p) level. AIM, atoms in molecules; NIC–OXA, nicotinamide–oxalic acid.
Geometrical parameter (bond length) and topological parameters for bonds of interacting atoms of intermolecular hydrogen bonding of NIC–OXA salt: electron density (ρBCP), Laplacian of electron density (∇2ρBCP), electron kinetic energy density (GBCP), electron potential energy density (VBCP), total electron energy density (HBCP) at bond critical point (BCP), and estimated interaction energy (Eint).
| Hydrogen bonds | Bond length (Å) | ρBCP (a.u.) | ∇2ρBCP (a.u.) | GBCP (a.u.) | VBCP (a.u.) | HBCP (a.u.) | Eint (kcal mol−1) | GBCP/ρBCP |
|---|---|---|---|---|---|---|---|---|
| N7–H8⋯O5 | 1.0077 | 0.0471 | 0.1015 | 0.0077 | −0.0407 | −0.0330 | −12.7698 | 0.1635 |
| N23–H24⋯O2 | 1.0077 | 0.0471 | 0.1015 | 0.0077 | −0.0407 | −0.0330 | −12.7698 | 0.1635 |
| C10–H22⋯O1 | 2.4165 | 0.0097 | 0.0378 | −0.0016 | −0.0062 | −0.0078 | −1.9453 | −0.1649 |
| C26–H38⋯O4 | 2.4165 | 0.0097 | 0.0378 | −0.0016 | −0.0062 | −0.0078 | −1.9453 | −0.1649 |
FIGURE 5HOMO-LUMO energy gap of NIC–OXA salt with orbitals participating in electronic transitions. HOMO, highest occupied molecular orbital; LUMO, lowest unoccupied molecular orbital; NIC–OXA, nicotinamide–oxalic acid.
Calculated EHOMO, ELUMO, energy band gap (EL–EH), chemical potential (μ), electro negativity (χ), global hardness (η), global softness (S), global electrophilicity index (ω), and maximum extent of charge transfer (ΔNmax) at 298.15 K for nicotinamide (NIC), oxalic acid (OXA), and NIC–OXA salt using B3LYP/6-311++G(d,p).
| Molecule | EH (eV) | EL (eV) | EL–EH (eV) | χ (eV) | μ (eV) | η (eV) | S (eV) | ω (eV) | ΔNmax |
|---|---|---|---|---|---|---|---|---|---|
| NIC | −7.3414 | −1.8058 | 5.5356 | 4.5736 | −4.5736 | 2.7678 | 0.1806 | 3.7788 | 1.6524 |
| OXA | −8.1669 | −2.5002 | 5.6667 | 5.3335 | −5.3335 | 2.8333 | 0.1765 | 5.0200 | 1.8824 |
| NIC–OXA salt | −7.1307 | −1.9861 | 5.1446 | 4.5584 | −4.5584 | 2.5723 | 0.1944 | 4.0390 | 1.7721 |
Note. NIC, nicotinamide; OXA, oxalic acid.
FIGURE 6Molecular electrostatic potential (MESP) map of NIC–OXA salt formed by mapping of total electron density over electrostatic potential in the gas phase. NIC–OXA, nicotinamide–oxalic acid.